We are live on
!
Find out more
ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
2L
1
22NW LP
Seattle,
Washington
| $21.9M | – | – | – |
|
| 2 |
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.73M | -$83.8K | -11,954 | -3% |
|
| 3 |
LCM
3
Laurion Capital Management
New York
| $1.51M | – | – | – |
|
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
| $1.16M | -$17.5K | -2,502 | -1% |
|
| 5 |
BFM
5
Boothbay Fund Management
New York
| $114K | -$17.5K | -2,502 | -13% |
|
| 6 |
6
BlackRock
New York
| $50K | -$1.12K | -160 | -2% |
|
| 7 |
7
UBS Group
Zurich,
Switzerland
| $6K | +$4.3K | +614 | +262% |
|
| 8 |
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$834 | -119 | -75% |
|